Lambert-Eaton myasthenic syndrome (LEMS) linked to an underlying lung cancer was successfully managed with four weekly intravenous, or into-the-vein, infusions of efgartigimod — a medication approved for treating myasthenia gravis (MG) — in an elderly man in China, according to a case report. LEMS and MG are both…